Regression of coronary atherosclerosis. Angiographic perspective

Area of Science:

• Cardiology
• Medical Imaging
• Pharmacology

Background:

• Coronary atherosclerosis progression is a significant concern in high-risk patients.
• Assessing interventions requires precise measurement of coronary artery lesions.
• Visual interpretation of coronary arteriography has limitations due to observer variability.

Purpose of the Study:

• To highlight the importance of quantitative coronary angiography in evaluating interventions for coronary atherosclerosis.
• To emphasize the limitations of visual assessment in detecting subtle changes in lesion diameter.
• To advocate for the use of precise measurement techniques in clinical trials.

Main Methods:

• Serial coronary arteriography in randomized controlled trials.
• Comparison of visual interpretation versus quantitative computer-assisted measurements.
• Focus on patients at high risk for coronary disease progression.

Main Results:

• Quantitative measurements significantly reduce inter- and intra-observer variability compared to visual assessment.
• Previous studies using visual assessment showed some benefit of cholestyramine and colestipol-niacin but lacked precision.
• Marked reduction in serum cholesterol is linked to preventing progression or inducing regression of atherosclerosis.

Conclusions:

• Quantitative angiographic measurement techniques are essential for accurate assessment of cholesterol-lowering interventions.
• Precise measurement is necessary to detect changes less than 20% in coronary lesion diameter.
• Future clinical trials should incorporate quantitative methods to reliably evaluate treatment efficacy.